Institutional investors hold a majority ownership of CELG through the 80.88% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2017, these large investors purchased a net $2.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARROWSTREET CAPITAL LP Bought 1.8 Million shares of Celgene
THE VANGUARD GROUP, INC. Bought 1.6 Million shares of Celgene
WELLINGTON MANAGEMENT CO. LLP Bought 1.6 Million shares of Celgene